Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
about
Familial gigantismStructure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma PredispositionNMR assignments of the FKBP-type PPIase domain of the human aryl-hydrocarbon receptor-interacting protein (AIP).The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor αIn-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantismCharacterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.Geographic-Related Differences of Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern EuropeAryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?Clinical and genetic aspects of familial isolated pituitary adenomasAugmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell LineFamilial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.The genetic background of acromegaly.Familial isolated pituitary adenomas: an emerging clinical entity.Diagnosis of acromegaly: state of the art.MicroRNAs: Suggested role in pituitary adenoma pathogenesis.The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.Epidemiology and etiopathogenesis of pituitary adenomas.The role of genetic and epigenetic changes in pituitary tumorigenesis.MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening.Should aip gene screening be recommended in family members of FIPA patients with R16H variant?AIP limits neurotransmitter release by inhibiting calcium bursts from the ryanodine receptor.AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation.Familial pituitary adenomas - who should be tested for AIP mutations?A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family.Pituitary Gene Signalling PathwayEpt7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases
P2860
Q27022947-0873F239-E78A-4812-8741-755EFB8C5318Q27675839-E2FD5DDD-B8DE-4C37-8D70-F98173D6D92AQ30318200-9B263F09-5F31-431C-AF9F-F2ADF7DD1083Q30473787-984BB6AE-3C4C-4834-AC2A-F62BBB0454B4Q33904569-18D60E15-574F-4290-BCC4-277A2473EAC1Q34729384-F2E957CD-0ECF-4B04-A9AE-D71C3D4D3DEBQ35640741-390F6094-460E-4A9B-B4CE-91CEDC7E7CE7Q35860858-9BAE6FD9-4285-477F-B7DF-CAB5FC67E821Q35865197-1AB7B273-CC87-4327-8049-7069F47FB263Q35895480-64CC776E-F3EE-4ADD-A3DA-0AC401201157Q36153987-F8777EA8-F2B0-4695-86C0-537A9A969036Q36724063-D504763C-4A09-4CA3-A886-AA440DFEB09FQ36838985-AC007DCB-44C9-4D6F-A18A-115B52BF4C14Q37678059-18009C62-AE5C-4437-BEE9-202AB2067C33Q38073256-16532803-A9E5-49A5-BA2E-E2E581DD91AFQ38131055-7A226882-266B-42D0-8BC1-5A20404FDA44Q38169540-EB7EEF56-0BDB-426E-86BB-39B553997964Q38173701-A2DA268C-F709-47DD-93D1-B15195CA123BQ38183762-8CB08FA0-1B6A-4330-95A7-59661E0236EAQ38274982-807E09D7-3BC5-45D6-894E-538C20F6C868Q38323442-D27D829D-CDF5-41F9-8502-BC60722D06E8Q42749595-9DEFEEC6-560F-44AA-BD6D-6150563BE18EQ43569673-73233AFC-0F71-40B4-91FD-5A102D477D64Q45327685-43E9ED9F-307E-44CA-8244-BE3B220CB703Q47124521-11016566-250F-446F-94C8-70DAA28869D6Q47735880-FC081BFD-3DCF-4375-84E5-015DD87CC272Q52651698-A601786F-B39E-45A9-AF83-2886DF483A21Q54987294-217F2806-2426-4B80-8C6D-489C05E227E0Q58616038-62004C25-1335-476D-A04B-BAC66790462BQ59129303-89DC8201-AD67-4F2C-8E92-CE677155506A
P2860
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@en
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@nl
type
label
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@en
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@nl
prefLabel
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@en
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@nl
P2093
P1476
Clinical, genetic and molecula ...... ted pituitary adenomas (FIPA).
@en
P2093
Ashley B Grossman
Harvinder S Chahal
J Paul Chapple
Lawrence A Frohman
Márta Korbonits
P304
P356
10.1016/J.TEM.2010.02.007
P577
2010-06-01T00:00:00Z